12:05 p.m. CT Saturday, June 13
This presentation will review the use of continuous glucose monitoring (CGM) devices in the hospital. Compared to the ambulatory setting, where CGM use is expanding, utilization of CGM systems in the inpatient setting is still considered investigational. However, by obtaining multiple glucose measurements every couple of minutes, CGM systems may benefit hospitalized patients with diabetes, providing intensive glucose monitoring. During the current COVID-19 pandemic health crisis, CGM devices have been further utilized to replace point-of-care glucose testing, even without an official FDA approval, in an attempt to reduce personal protective equipment (PPE) use and the risk of COVID-19 exposure. This talk will focus on the progress that has been achieved in the recent years and will review the limitations of the use of CGMs in the inpatient setting, given that existing CGMs are designed for the outpatient setting. We will also present evidence of whether a system that we named Glucose Telemetry System (GTS) and by which CGM glucose values are transmitted wirelessly from the bedside to a centralized monitor at the nursing station can decrease hypoglycemia in the hospital setting.